Literature DB >> 18277832

Adverse baseline physiological and psychosocial profiles of women enrolled in a cardiac rehabilitation clinical trial.

Theresa M Beckie1, Gerald F Fletcher, Jason W Beckstead, Douglas D Schocken, Mary E Evans.   

Abstract

PURPOSE: Coronary heart disease (CHD) remains the leading cause of death in women. Despite positive outcomes associated with cardiac rehabilitation (CR), investigations of women are sparse. This article presents the baseline physiological and psychosocial profiles of 182 women in the Women's-Only Cardiac Rehabilitation study.
METHOD: Women were randomized to a women's-only motivational interviewing or traditional CR group. Physiological measures included lipid profiles, body mass index, functional capacity, and anthropomorphic measures. Psychosocial measures included optimism, hope, social support, anxiety, depression, quality of life, and health perceptions. The median age was used to split the sample to examine data on 92 younger (< or = 64 years) and 90 older (>64 years) women.
RESULTS: With a mean age of 63 years, 66.5% were white, 47% were retired, and 54% were married. Most women were physically inactive (83%), hypertensive (76%), and overweight (56%). Most women (71.4%) met the criteria for metabolic syndrome. Younger women demonstrated significantly worse psychosocial profiles than older women. More of the younger women (64%) had depressive symptoms than older women (37%). Younger women demonstrated a mean Center for Epidemiological Studies Depression Scale score of 20.8 +/- 12.4, whereas older women had a substantially lower mean score of 14.9 +/- 9.5 (P < .001). Younger participants also reported significantly more anxiety than older participants (38.8 +/- 13.4 vs 32.8 +/- 10.6, P < .001).
CONCLUSION: Younger women enrolled in a CR clinical trial had adverse baseline risk factor profiles placing them at high risk for disease progression.

Entities:  

Mesh:

Year:  2008        PMID: 18277832     DOI: 10.1097/01.HCR.0000311510.16226.6e

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   2.081


  8 in total

1.  Predicting cardiac rehabilitation attendance in a gender-tailored randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead
Journal:  J Cardiopulm Rehabil Prev       Date:  2010 May-Jun       Impact factor: 2.081

2.  The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: A randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead; Douglas D Schocken; Mary E Evans; Gerald F Fletcher
Journal:  Int J Nurs Stud       Date:  2010-07-07       Impact factor: 5.837

3.  Nature, availability, and utilization of women-focused cardiac rehabilitation: a systematic review.

Authors:  Taslima Mamataz; Gabriela L M Ghisi; Maureen Pakosh; Sherry L Grace
Journal:  BMC Cardiovasc Disord       Date:  2021-09-23       Impact factor: 2.174

4.  Physiological and exercise capacity improvements in women completing cardiac rehabilitation.

Authors:  Theresa M Beckie; Jason W Beckstead; Kevin Kip; Gerald Fletcher
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Jan-Feb       Impact factor: 2.081

5.  Improvements in heart rate recovery among women after cardiac rehabilitation completion.

Authors:  Theresa M Beckie; Jason W Beckstead; Kevin E Kip; Gerald Fletcher
Journal:  J Cardiovasc Nurs       Date:  2014 Jan-Feb       Impact factor: 2.083

6.  The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.

Authors:  Theresa M Beckie; Jason W Beckstead; Maureen W Groer
Journal:  J Cardiovasc Nurs       Date:  2010 Jan-Feb       Impact factor: 2.083

7.  Examining the challenges of recruiting women into a cardiac rehabilitation clinical trial.

Authors:  Theresa M Beckie; Mary Ann Mendonca; Gerald F Fletcher; Douglas D Schocken; Mary E Evans; Steven M Banks
Journal:  J Cardiopulm Rehabil Prev       Date:  2009 Jan-Feb       Impact factor: 2.081

Review 8.  Lifestyle interventions for cardiovascular risk reduction in women with breast cancer.

Authors:  M Tish Knobf; Jessica Coviello
Journal:  Curr Cardiol Rev       Date:  2011-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.